Correction: Alamri et al. Enhancement of the Protective Activity of Vanillic Acid against Tetrachloro-Carbon (CCl) Hepatotoxicity in Male Rats by the Synthesis of Silver Nanoparticles (AgNPs). 2022, , 8308.

In the original publication [...

Nanoemulsions of L. (Decaffeinated) and L. Extracts as a Novel Approach for the Treatment of Carbon Tetrachloride-Mediated Liver Fibrosis.

Liver fibrosis is a condition characterized by the excessive buildup of scar tissue in the liver. This scarring occurs as a result of chronic liver damage, often caused by conditions such as hepatitis, alcohol abuse, certain metabolic disorders, genetic abnormalities, autoimmunity, and noninfectious diseases such as fatty liver which leads to liver fibrosis. Nanoparticles have gained attention in recent years as potential therapeutic agents for liver fibrosis.

Enhancement of the Protective Activity of Vanillic Acid against Tetrachloro-Carbon (CCl) Hepatotoxicity in Male Rats by the Synthesis of Silver Nanoparticles (AgNPs).

In the current study, the hepatoprotective activity of vanillic acid, silymarin, and vanillic acid-loaded silver nanoparticles (AgNPs) against CCl-induced hepatotoxicity was tested in male rats for four weeks. Thirty male rats were divided into five groups ( = 6). The 1st group was a negative control, the 2nd group was a positive control, the 3rd group was treated with 100 mg/kg b.